Effect of Human Adenovirus 36 on Response to Metformin Monotherapy in Obese Mexican Patients with Type 2 Diabetes: A Prospective Cohort Study.
human adenovirus-36
response to metformin
type 2 diabetes
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
07 07 2023
07 07 2023
Historique:
received:
30
05
2023
revised:
04
07
2023
accepted:
05
07
2023
medline:
31
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Human adenovirus 36 (HAdV-36) has been associated with obesity and changes in glucose and lipid metabolism. The virus has been reported to increase insulin sensitivity and paradoxically promote weight gain. Because of its effects on metabolism, infection with the virus could alter the response to several drugs used to treat type 2 diabetes (DM2), such as metformin. The aim of this study was to test whether HAdV-36 affects the response to metformin in a group of obese patients with DM2. In a prospective cohort study, 103 obese patients with newly diagnosed DM2 were divided into two groups based on their HAdV-36 seropositivity (+HAdV-36 and -HAdV-36). Weight, glucose, cholesterol, triglycerides, body mass index, body fat percentage, and waist and hip circumference were measured and compared in both groups at baseline and after 45 days of metformin treatment. Only glucose was significantly lower in the +HAdV-36 group at baseline, while all other variables were similar between the two study groups. After 45 days of follow-up, it was observed that the effect of metformin did not differ between the groups, but the variables improved significantly after treatment. In this study, we did not find that HAdV-36 had an effect on the response to metformin in obese patients with DM2.
Identifiants
pubmed: 37515200
pii: v15071514
doi: 10.3390/v15071514
pmc: PMC10386570
pii:
doi:
Substances chimiques
Metformin
9100L32L2N
Hypoglycemic Agents
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Diabetes Complications. 2013 Mar-Apr;27(2):191-9
pubmed: 23246247
Biochimie. 2016 May;124:3-10
pubmed: 25450249
Nat Commun. 2022 Feb 16;13(1):907
pubmed: 35173150
Int J Obes (Lond). 2005 Mar;29(3):281-6
pubmed: 15611785
Diabetes Care. 2015 Aug;38(8):1449-55
pubmed: 25986661
Diabetes Care. 2023 Jan 1;46(Suppl 1):S140-S157
pubmed: 36507650
Diabetes Care. 2011 Feb;34(2):518-23
pubmed: 21270207
Ethn Dis. 2020 Apr 2;30(Suppl 1):211-216
pubmed: 32269463
Int J Obes Relat Metab Disord. 2000 Aug;24(8):989-96
pubmed: 10951537
Diabetes Care. 2013 Mar;36(3):701-7
pubmed: 23160725
Int J Obes (Lond). 2015 Dec;39(12):1757-60
pubmed: 26303351
Obes Facts. 2013;6(3):269-78
pubmed: 23751249
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002966
pubmed: 16034881
Viruses. 2022 Jul 27;14(8):
pubmed: 36016261
Int J Obes (Lond). 2021 Jun;45(6):1342-1356
pubmed: 33753885
Dig Dis Sci. 2012 Feb;57(2):535-44
pubmed: 21953137
Front Nutr. 2021 Jun 02;8:671004
pubmed: 34150828
Molecules. 2018 Jan 28;23(2):
pubmed: 29382104
Obes Res Clin Pract. 2021 Jan-Feb;15(1):64-68
pubmed: 33386253
J Clin Hypertens (Greenwich). 2010 Dec;12(12):973-82
pubmed: 21122063
Diabetes. 2014 Aug;63(8):2590-9
pubmed: 25060887
Stem Cells. 2008 Apr;26(4):969-78
pubmed: 18203674
Clin Ther. 2010 Sep;32(10):1720-8
pubmed: 21194594
N Engl J Med. 2004 Sep 9;351(11):1106-18
pubmed: 15356308
Curr Pharm Des. 2021;27(8):1061-1067
pubmed: 33355048
Front Immunol. 2018 Jan 31;9:89
pubmed: 29445375
Int J Endocrinol. 2013;2013:463194
pubmed: 24324491
J Biol Chem. 2012 Dec 28;287(53):44121-9
pubmed: 23135276
Eur J Drug Metab Pharmacokinet. 2021 Mar;46(2):185-203
pubmed: 33538960
Front Public Health. 2022 Dec 21;10:1029358
pubmed: 36620244
Nat Rev Endocrinol. 2016 Nov;12(11):626
pubmed: 27564711
J Steroid Biochem Mol Biol. 2010 Oct;122(1-3):65-73
pubmed: 20035866
Int J Obes (Lond). 2014 Feb;38(2):285-91
pubmed: 23732656
Curr Med Res Opin. 2006;22 Suppl 2:S39-48
pubmed: 16914074
Sci Rep. 2020 May 15;10(1):8107
pubmed: 32415247
Int J Environ Res Public Health. 2022 Feb 16;19(4):
pubmed: 35206434
Metabolism. 2001 Dec;50(12):1457-61
pubmed: 11735093
Rev Med Virol. 2015 Nov;25(6):379-87
pubmed: 26352001
Diabetes Care. 2022 Jan 1;45(Suppl 1):S125-S143
pubmed: 34964831
J Intern Med. 2004 Jul;256(1):1-14
pubmed: 15189360
Cardiovasc Diabetol. 2011 Jul 14;10:65
pubmed: 21756323
Endocrinology. 2011 Oct;152(10):3648-60
pubmed: 21791563
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
Obesity (Silver Spring). 2006 Nov;14(11):1905-13
pubmed: 17135605
Exp Clin Endocrinol Diabetes. 2013 Jan;121(1):27-31
pubmed: 23147210
Int J Obes (Lond). 2008 Jan;32(1):61-72
pubmed: 17653063
Diabetes. 2008 Jul;57(7):1805-13
pubmed: 18420488
Ann Med. 2014 Nov;46(7):539-46
pubmed: 25045929
Lancet Infect Dis. 2011 Dec;11(12):963-9
pubmed: 22115071